 |
  |
||||||||
 |
|||||||||
|
|||||||||
 |
|||||||||
 |
|||||||||
|
|
 |
|
|
R & D |
|
|
|
Pipeline |
|
|
|
Bepreve™ |
|
|
|
Xibrom™
|
|
|
|
Istalol®
|
|
|
|
Vitrase® |
|
|
|
Xibrom XiDay (once-daily) |
|
|
|
BromfenacLow-Dose for Dry Eye
|
|
|
|
Bepotastine Nasal Spray |
|
|
|
Ecabet Sodium
|
|
|
|
T-Pred™ |
|
|
|
|
 |
|||||||
|
|
|
|||||
|
|||||||
|
ISTA is developing a strong product pipeline to fuel future growth, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S.
To read about the ISTA product pipeline, please click here. |
|||||||
|
|||||||
| © 2009 ISTA Pharmaceuticals. All Rights Reserved. Disclaimer | Privacy Policy |